EV
Publicaties op Oncologisch.com
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Place...
Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-...
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of EN...
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovar...
Tisotumab vedotin als tweede/derdelijns bij recidief cervixcarcinoom: innovaTV 301 fase III
Durvalumab plus carboplatine-paclitaxel plus onderhoud durvalumab met of zonder olaparib bij ovariumcarcinoom: DUO-O/ENGOT-OV46 fase III